Article D6124-134-10
The authorisation holder has an organisation enabling it to record in writing, in order to ensure traceability, referrals of patients for the continuation of systemic cancer drug treatments close to t…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3631–3640 of 57757 articles for “Art. s. L 623-4 to L 623-13”
The authorisation holder has an organisation enabling it to record in writing, in order to ensure traceability, referrals of patients for the continuation of systemic cancer drug treatments close to t…
The authorised establishment must : 1° Comply with the medication circuit and take into account the criteria in the certification manual for healthcare establishments; 2° Formalise the steps involved…
For intensive chemotherapy leading to a foreseeable aplasia of more than eight days, the health establishment must have, in application of 3° of article R. 6123-94-2, during the treatment period, a pe…
I.-The holder of the systemic cancer drug treatment authorisation is organised in such a way that, in order to guarantee continuity of care for the patient, the following information can be communicat…
I.-The consultation for a first prescription of a systemic drug treatment for cancer mentioned in 2° of I of article R. 6123-94, is carried out on the authorised site, during a one-to-one interview wi…
I.-Health establishments authorised for interventional medicine, surgery or radiology and holders of authorisations for medical care and rehabilitation or home hospitalisation, applying systemic cance…
I.-All the information relating to the administration schedule for anti-cancer medicinal products, their international non-proprietary name, the dose administered, the carrier solute used, the route o…
I.-The notification referred to in III of article L. 3512-17 includes the following information: 1° A detailed description of the product and instructions for its use; 2° The information on the ingred…
The declaration provided for in article L. 1342-1 is drawn up for any mixture classified as hazardous within thirty days of it being placed on the market. It is sent to a body designated by order of t…
…the corresponding transport costs are not covered by the funding bodies, the Prefect may reimburse all transport costs incurred by trainees residing in Guadeloupe, French Guiana, Martinique, La Réunio…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More